
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by
our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact
Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

https://www.wsj.com/articles/death-of-man-who-received-a-pig-heart-transplant-remains-a-mystery-11655933404
Listen to article
(2 minutes)
Doctors can’t fully explain the death of the first recipient of a genetically modified pig heart, but they offered several theories in a new study—and said clinical trials of pig-to-human organ transplantation should begin despite the continuing mystery.
David Bennett, a 57-year-old handyman from Hagerstown, Md., received the heart in an experimental operation in January at the University of Maryland Medical Center in Baltimore and died two months later. The surgery—an attempt to extend the life of a desperately ill patient who had been kept alive for weeks on a machine that took over the functions of his heart and lungs—came after the U.S. Food and Drug Administration issued a special emergency authorization for it.
Continue reading your article witha WSJ membership
WSJ Membership
Customer Service
Tools & Features
Ads
More
Dow Jones Products
WSJ Membership
Customer Service
Tools & Features
Ads
More
Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by
our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact
Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

